Zobrazeno 1 - 10
of 278
pro vyhledávání: '"W. Douglas Weaver"'
Autor:
Claes Held, Harvey D. White, Ralph A. H. Stewart, Andrzej Budaj, Christopher P. Cannon, Judith S. Hochman, Wolfgang Koenig, Agneta Siegbahn, Philippe Gabriel Steg, Joseph Soffer, W. Douglas Weaver, Ollie Östlund, Lars Wallentin
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 10 (2017)
BackgroundEvaluation of cardiovascular prognosis in patients with stable coronary heart disease is based on clinical characteristics and biomarkers indicating dysglycemia, dyslipidemia, renal dysfunction, and possibly cardiac dysfunction. Inflammatio
Externí odkaz:
https://doaj.org/article/d693d2d4a5754786bb05e7531ef50e67
Autor:
Lars Wallentin, Claes Held, Paul W. Armstrong, Christopher P. Cannon, Richard Y. Davies, Christopher B. Granger, Emil Hagström, Robert A. Harrington, Judith S. Hochman, Wolfgang Koenig, Sue Krug‐Gourley, Emile R. Mohler, Agneta Siegbahn, Elizabeth Tarka, Philippe Gabriel Steg, Ralph A. H. Stewart, Robert Weiss, Ollie Östlund, Harvey D. White, Andrzej Budaj, Diego Ardissino, Alvaro Avezum, Philip E. Aylward, Alfonso Bryce, Hong Chen, Ming‐Fong Chen, Ramon Corbalan, Anthony J. Dalby, Nicolas Danchin, Robbert J. De Winter, Stefan Denchev, Rafael Diaz, Moses Elisaf, Marcus D. Flather, Assen R. Goudev, Liliana Grinfeld, Steen Husted, Hyo‐Soo Kim, Ales Linhart, Eva Lonn, José López‐Sendón, Athanasios J. Manolis, José C. Nicolau, Prem Pais, Alexander Parkhomenko, Terje R. Pedersen, Daniel Pella, Marco A. Ramos‐Corrales, Mikhail Ruda, Mátyás Sereg, Saulat Siddique, Peter Sinnaeve, Piyamitr Sritara, Henk P. Swart, Rody G. Sy, Tamio Teramoto, Hung‐Fat Tse, W. Douglas Weaver, Margus Viigimaa, Dragos Vinereanu, Junren Zhu
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 6 (2016)
BackgroundWe evaluated lipoprotein‐associated phospholipase A2 (Lp‐PLA2) activity in patients with stable coronary heart disease before and during treatment with darapladib, a selective Lp‐PLA2 inhibitor, in relation to outcomes and the effects
Externí odkaz:
https://doaj.org/article/43af20ec4c304e52a6da8a25a7ce73f4
Autor:
Christopher P. Cannon, Robert F. Storey, Lars Wallentin, Agneta Siegbahn, W. Douglas Weaver, Stefan James, Anders Himmelmann, Philippe Gabriel Steg, Richard C. Becker, Hugo A. Katus, Axel Åkerblom, Tatevik Ghukasyan Lakic
Publikováno v:
Clinical Cardiology
Background We aimed to assess associations between circulating IL‐18 concentrations and cardiovascular outcomes in patients with acute coronary syndromes (ACS). Hypothesis and Methods Plasma IL‐18 concentrations were measured at admission, discha
Autor:
Matthew A. Cavender, Robert A. Harrington, Gregg W. Stone, Ph. Gabriel Steg, C. Michael Gibson, Christian W. Hamm, Matthew J. Price, Renato D. Lopes, Sergio Leonardi, Efthymios N. Deliargyris, Jayne Prats, Kenneth W. Mahaffey, Harvey D. White, Deepak L. Bhatt, Kurt Huber, Valter C. Lima, Julia B. Jorgova-Makedonska, Petr Widimský, Bondo Kobulia, Peter W. Radke, Ezio Bramucci, Adam Witkowski, Evgeny Shlyakhto, Frans Van de Werf, David P. Faxon, E. Magnus Ohman, Freek W.A. Verheugt, W. Douglas Weaver, Jan G.P. Tijssen, Matthew Wilson, Stacey Mangum, Chiara Melloni, Matthew J. Brennan, Pierluigi Tricoci, Robert Harrison, Pedro Barros, Luciana Armaganijan, Monique Anderson, Akshay Bagai, Philippe Généreux, Sorin J. Brener, Laura LaSalle, Werner Benzer, Georg Delle-Karth, Franz Leisch, Jamil Abdalla Saad, Alexandre Abizaid, Carlos Augusto Formiga Areas, Expedito E. Ribeiro, Fabio Rossi Dos Santos, Rogerio Tadeu Tumelero, Roberto Vieira Botelho, Borislav Atzev, Boicho Boichev, Georgi Grigorov, Nikolay Penkov, Ivo Petrov, Boris Zehirov, Pavel Cervinka, Zdenek Coufal, Petr Hajek, David Horak, Petr Kala, Petr Kmonicek, Viktor Kocka, Jan Mrozek, Stanislav Simek, Jan Sitar, Josef Stasek, Frantisek Tousek, Gulnara Chapidze, Nodar Emukhvari, George Khabeishvili, Merab Mamatsashvili, Tamaz Shaburishvili, Steffen Behrens, Harald Darius, Martin Dissmann, Stephan Fichtlscherer, Wolfgang Franz, Tobias Geisler, Sabine Genth-Zotz, Britta Goldmann, Hubertus Heuer, Stefan Hoffmann, Andreas Mugge, Tudor Poerner, Peter Radke, Gert Richardt, Christoph Stellbrink, Nikos Werner, Stefano De Servi, Gennaro Galasso, Alberto Menozzi, Giuseppe Musumeci, Andrea Picchi, Patrizia Presbitero, Gerard Devlin, Alexander Sasse, Douglas Scott, Ralph Stewart, Szyszka Andrzej, Witold Dubaniewicz, Zbigniew Gasior, Jaroslaw Kasprzak, Andrzej Kleinrok, Zdzislawa Kornacewicz-Jach, Andrzej Rynkiewicz, Cezary Sosnowski, Radoslaw Targonski, Jaroslaw Trebacz, Elzbieta Zinka, Olga Barbarash, Yakov Dovgalevsky, Ivan Gordeev, Svetlana Kalinina, Elena Kosmachova, Valentin Markov, Prokhor Pavlov, Sergey Shalaev, Zaur Shogenov, Irina Sukmanova, Elena Vasilieva, Alexey Yakovlev, Sarana Boonbaichaiyapruck, Noppadol Chamnarnphol, Pinij Kaewsuwanna, Srun Kuanprasert, Dilok Piyayotai, Maged Amine, Dominick Angiolillo, Imran Arif, James Blankenship, Emmanouil Brilakis, Michael Chan, Joseph Cinderella, Brent Davis, Chandanreddy Devireddy, Mark Dorogy, John Douglas, Norman Ferrier, Daniel Fisher, Robert Foster, William French, John Galla, Lawrence Gimple, Harinder Gogia, Prospero Gogo, Raghava Gollapudi, Luis Gruberg, James Hermiller, Richard Heuser, Robert Iwaoka, Zubair Jafar, Carey Kimmelstiel, Scott Kinlay, James Leggett, Pierre Leimgruber, Dustin Letts, Michael Lipsitt, Reginald Low, Joaquin Martinez-Arraras, Marc Mayhew, Brent McLaurin, Paul McWhirter, Ayoub Mirza, Brian Negus, Thomas Nygaard, William O’Riordan, Richard Paulus, John Petersen, Hector Picon, Mark Picone, Ernesto Rivera, David Rizik, Arsenio Rodriguez, Jorge Saucedo, J. Christopher Scott, Virender Sethi, Adhir Shroff, Craig Siegel, Douglas Spriggs, Daniel Steinberg, Michael Stillabower, Thomas Stuckey, Jose Suarez, Jeffrey Tauth, Dogan Temizer, Mladen Vidovich, Michele Voeltz, Jonathan Waltman, Michael Wilensky
Publikováno v:
Circulation. Cardiovascular Interventions
Circulation. Cardiovascular interventions, 15(1). Lippincott Williams and Wilkins
Circulation. Cardiovascular interventions, 15(1). Lippincott Williams and Wilkins
Supplemental Digital Content is available in the text.
Background: Thrombotic events are reduced with cangrelor, an intravenous P2Y12 inhibitor. We sought to characterize the timing, number, and type of early events (within 2 hours of randomizat
Background: Thrombotic events are reduced with cangrelor, an intravenous P2Y12 inhibitor. We sought to characterize the timing, number, and type of early events (within 2 hours of randomizat
Publikováno v:
Neurology
ObjectiveTo assess the safety and efficacy of elamipretide, an aromatic-cationic tetrapeptide that readily penetrates cell membranes and transiently localizes to the inner mitochondrial membrane where it associates with cardiolipin, in adults with pr
Autor:
Lars Wallentin, Christopher P. Cannon, Maria Bertilsson, Stefan James, Evangelos Giannitsis, W. Douglas Weaver, Frederic Kontny, Robert A. Harrington, Anders Himmelmann, Philippe Gabriel Steg, Daniel Lindholm, Richard C. Becker, Robert F. Storey, Matthijs A. Velders, Agneta Siegbahn
Publikováno v:
Clinical Chemistry. 63:573-584
BACKGROUND Risk stratification in non–ST-elevation acute coronary syndrome (NSTE-ACS) is currently mainly based on clinical characteristics. With routine invasive management, angiography findings and biomarkers are available and may improve prognos
Autor:
Uptal D. Patel, Judith S. Hochman, Manesh R. Patel, Rajendra H. Mehta, W. Douglas Weaver, Robert M. Clare, Paul W. Armstrong, John P. Vavalle, Renato D. Lopes, Sean van Diepen, Karen S. Pieper, Christopher B. Granger
Publikováno v:
American Heart Journal. 173:57-66
Among patients presenting with ST-segment elevation myocardial infarction (STEMI) for primary percutaneous coronary intervention (PCI), the associations between clinical outcomes and both baseline renal function and the development of acute kidney in
Autor:
Wolfgang Koenig, Lars Wallentin, Christopher P. Cannon, Philippe Gabriel Steg, Ralph A.H. Stewart, Judith S. Hochman, Agneta Siegbahn, Ollie Östlund, W. Douglas Weaver, Harvey D. White, Andrzej Budaj, Claes Held, Joseph Soffer
Publikováno v:
Journal of the American Heart Association. 6
Background Evaluation of cardiovascular prognosis in patients with stable coronary heart disease is based on clinical characteristics and biomarkers indicating dysglycemia, dyslipidemia, renal dysfunction, and possibly cardiac dysfunction. Inflammati
Autor:
Matthew W. Sherwood, Frederick A. Masoudi, Kalon K.L. Ho, David Dai, Eric D. Peterson, John C. Messenger, J. Matthew Brennan, W. Douglas Weaver
Publikováno v:
JACC: Cardiovascular Interventions. 8:10-16
Objectives The goal of this study was to examine the calibration of a validated risk-adjustment model in very high-risk percutaneous coronary intervention (PCI) cases and assess whether sites' case mix affects their performance ratings. Background Th
Autor:
David R. Holmes, John S. Rumsfeld, Laura Mauri, Robert W. Yeh, Ralph G. Brindis, Priscilla Driscoll-Shempp, W. Douglas Weaver, Matthew T. Roe, Matthew J. Czarny, Sunghee Kim, Sharon-Lise T. Normand, Dean J. Kereiakes
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 8:96-102
Background— The Dual Antiplatelet Therapy Study is large streamlined clinical trial designed to evaluate antiplatelet treatment strategies in a broadly inclusive population of subjects treated with coronary stents. Whether large streamlined trials